3 strategies for connecting your alumni to a cause
The Advisory Board Company | The Advancement Forum | Advancement Insights Blog
Published: April 24, 2017
Kids these days.
Annual giving directors from private and public institutions of all sizes tell us that millennials have them scratching their heads. A socially conscious generation, they’re quick to open up their wallets for a variety of causes, but also skeptical about giving back to universities. 75% of millennials say that they’d donate to another nonprofit before making a gift to their alma maters.
Why the disconnect?
How to transform millennials into monthly donors
The Advisory Board Company | The Advancement Forum | Advancement Insights Blog
Published: May 16, 2017
Millennials. It seems that they’ve done everything from kill the movie-going experience to spend all their retirement money on avocado toast.
Whether these claims are true or not, one thing is clear: it's becoming harder and harder to obtain and count on millennial alumni giving.
How the Cleveland Clinic saved $1M by reducing cancer patient readmissions
The Advisory Board Company | The Oncology Roundtable | Oncology Rounds Blog
Published: June 6, 2016
Unplanned readmissions are costly, adding up to an estimated $12 billion a year for Medicare. Small steps, such as ensuring that patients leave the hospital with clear discharge instructions, can decrease the likelihood of readmissions by 30%. Yet, 91% of chronically ill patients do not receive a written care plan at discharge, and 72% leave the hospital without scheduling a follow-up appointment.
Fire trucks and frogs: 5 ways to reduce the need for imaging sedation in kids
The Advisory Board Company | Imaging Partnership Performance | The Reading Room Blog
Published: June 29, 2016
When it comes to kid-friendly imaging, safety concerns are often top-of-mind. Pediatric imaging providers regularly note the challenges associated with sedating children and seek ways to reduce the need for sedation and its associated risks whenever possible.
We took a deeper look at the way pediatric imaging programs are decreasing the need for sedation—and effective strategies one organization put into practice.
Here’s why patients don’t enroll in your clinical trials
The Advisory Board Company | The Oncology Roundtable | Oncology Rounds Blog
Published: October 17, 2016
With the announcement of Vice President Biden’s Cancer Moonshot earlier this year, there’s been a resurgence of national interest in cancer research—and for good reason. Clinical trials are responsible for most of the advances we’ve made in cancer treatment so far. We know that they’ll be critical in continuing to improve treatment.
But our researchers have noticed a disturbing trend. Despite the importance of clinical trials, relatively few cancer patients participate in them. To figure out why, Memorial Sloan Kettering surveyed almost 2,000 consumers and providers—keep reading to find out what they learned.
Mythbusters: The path to value-based care
For several years now, you’ve certainly been hearing about the transition to value-based payment. But enough talk. At the end of the day, are providers really taking on downside financial risk with payers?
Our colleagues at the Financial Leadership Council surveyed over 100 CFOs to answer this question—and the short answer is yes and no: yes, there’s been movement toward value-based payment, but no, hospitals aren’t putting a lot of dollars at risk through these types of contracts.
